These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 495289)

  • 1. Refuting the UGDP conclusion that insulin treatment does not prevent vascular complications in diabetes.
    Kilo C; Williamson JR; Choi SC; Miller JP
    Adv Exp Med Biol; 1979; 119():307-11. PubMed ID: 495289
    [No Abstract]   [Full Text] [Related]  

  • 2. Effects of hypoglycemic agents on vascular complications in patients with adult-onset diabetes. 3. Clinical implications of UGDP results.
    Goldner MG; Knatterud GL; Prout TE
    JAMA; 1971 Nov; 218(9):1400-10. PubMed ID: 4941698
    [No Abstract]   [Full Text] [Related]  

  • 3. The UGDP--tolbutamide and mortality.
    Knowles HC
    Horm Metab Res; 1974; Suppl 4():186-8. PubMed ID: 4609432
    [No Abstract]   [Full Text] [Related]  

  • 4. Effects of hypoglycemic agents on vascular complications in patients with adult-onset diabetes. IV. A preliminary report on phenoformin results.
    Knatterud GL; Meinert CL; Klimt CR; Osborne RK; Martin DB
    JAMA; 1971 Aug; 217(6):777-84. PubMed ID: 4935344
    [No Abstract]   [Full Text] [Related]  

  • 5. [Considerations on diabetic angiopathies. Relations to hypoglycemic treatments].
    Lubetzki J
    Nouv Presse Med; 1972 Mar; 1(11):715-8. PubMed ID: 5022249
    [No Abstract]   [Full Text] [Related]  

  • 6. The UGDP study.
    Salsburg DS
    JAMA; 1971 Dec; 218(11):1704-5. PubMed ID: 4940315
    [No Abstract]   [Full Text] [Related]  

  • 7. [For a more physiological treatment of diabetes mellitus. Is it possible to prevent the appearance of angiopathy?].
    Tutin M; Tchobroutsky G
    Presse Med (1893); 1970 Jun; 78(30):1351 passim. PubMed ID: 5421550
    [No Abstract]   [Full Text] [Related]  

  • 8. Insulin infusion systems, diabetic control, and microvascular complications.
    Watkins PJ
    Br Med J; 1980 Feb; 280(6211):350-2. PubMed ID: 6988037
    [No Abstract]   [Full Text] [Related]  

  • 9. [Causes of death in diabetes mellitus].
    Akhmetzianov AM; Mazovetskiĭ AG; Kliachko VR
    Probl Endokrinol (Mosk); 1975; 21(1):103-11. PubMed ID: 1094446
    [No Abstract]   [Full Text] [Related]  

  • 10. Effects of hypoglycemic agents on vascular complications in patients with adult-onset diabetes. VII. Mortality and selected nonfatal events with insulin treatment.
    Knatterud GL; Klimt CR; Levin ME; Jacobson ME; Goldner MG
    JAMA; 1978 Jul; 240(1):37-42. PubMed ID: 351218
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The UGDP and insulin therapy.
    Skyler JS
    Diabetes Care; 1978; 1(5):328-9. PubMed ID: 720187
    [No Abstract]   [Full Text] [Related]  

  • 12. [Aiming for a normal blood sugar and prevention of diabetic micro-angiopathy and neuropathy].
    Reitsma WD
    Ned Tijdschr Geneeskd; 1977 Nov; 121(45):1815-7. PubMed ID: 337166
    [No Abstract]   [Full Text] [Related]  

  • 13. University Group Diabetes Program revisited.
    Barclay WR
    JAMA; 1978 Jul; 240(4):377-8. PubMed ID: 660876
    [No Abstract]   [Full Text] [Related]  

  • 14. [Intensified treatment of diabetes mellitus and prevention of the development or progression of complications].
    Kawamori R
    Nihon Naika Gakkai Zasshi; 1997 Mar; 86(3):358-64. PubMed ID: 9198611
    [No Abstract]   [Full Text] [Related]  

  • 15. A study of the effects of hypoglycemic agents on vascular complications in patients with adult-onset diabetes. II. Mortality results.
    Meinert CL; Knatterud GL; Prout TE; Klimt CR
    Diabetes; 1970; 19():Suppl:789-830. PubMed ID: 4926376
    [No Abstract]   [Full Text] [Related]  

  • 16. Control of blood glucose and diabetic vascular disease.
    Siperstein MD; Foster DW; Knowles HC; Levine R; Madison LL; Roth J
    N Engl J Med; 1977 May; 296(18):1060-3. PubMed ID: 846550
    [No Abstract]   [Full Text] [Related]  

  • 17. A progress report on the University Group Diabetes Program.
    Prout TE
    Int J Clin Pharmacol Biopharm; 1975 Jul; 12(1-2):244-51. PubMed ID: 809369
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A case for oral insulin therapy in the prevention of diabetic micro- and macroangiopathy.
    Gwinup G; Elias AN; Vaziri ND
    Int J Artif Organs; 1990 Jul; 13(7):393-5. PubMed ID: 2205590
    [No Abstract]   [Full Text] [Related]  

  • 19. Effect of blood sugar control on the microangiopathy of diabetes mellitus.
    Verso MA; Targovnik JH
    Ariz Med; 1981 Jul; 38(7):519-20. PubMed ID: 7023426
    [No Abstract]   [Full Text] [Related]  

  • 20. Effects of hypoglycemic agents on vascular complications in patients with adult-onset diabetes. VIII. Evaluation of insulin therapy: final report.
    Diabetes; 1982 Nov; 31 Suppl 5():1-81. PubMed ID: 6757026
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.